Skip to main content
RPG Life Sciences Limited logo

RPG Life Sciences Limited — Investor Relations & Filings

Ticker · RPGLIFE ISIN · INE105J01010 LEI · 335800O9C9JKWKXY5Y66 BSE.NS Manufacturing
Open in API
Filings indexed 814 across all filing types
Latest filing 2023-05-12 Regulatory Filings
Country IN India
Listing BSE.NS RPGLIFE

About RPG Life Sciences Limited

https://www.rpglifesciences.com

RPG Life Sciences Limited is an integrated pharmaceutical enterprise engaged in the development, manufacturing, and marketing of a diverse range of generic and branded formulations, as well as Active Pharmaceutical Ingredients (APIs). The company operates across several therapeutic segments, including nephrology, oncology, cardiology, rheumatology, and gastroenterology. It maintains a significant presence in the immunosuppressant market, providing critical medications for transplant recipients. With a focus on research and development, the organization produces complex molecules and finished dosages that cater to both domestic and international healthcare markets. Its manufacturing facilities adhere to stringent global quality standards, enabling the supply of essential medicines to regulated and semi-regulated markets worldwide. The portfolio includes a mix of legacy brands and specialty products designed to address chronic and acute medical conditions.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of duplicate share certificates under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is an official notification about share certificate issuance, not a financial report or earnings release. The content is regulatory compliance related to share certificates, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like share issue announcements or director dealings. The document length is short and it is a formal regulatory communication.
2023-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the availability of the transcript of the earnings call for the quarter and year ended March 31, 2023. It explicitly states that the transcript has been made available on the company's website and requests the exchanges to take note and disseminate the information. The document itself does not contain the transcript but is an announcement about the transcript's availability. The document length is short (1238 characters), and it fits the pattern of a Regulatory Filing (RNS) as it is a notification to the exchange rather than the transcript itself. Therefore, the correct classification is Regulatory Filings (RNS).
2023-05-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the availability of the audio recording of the earnings call for the audited financial results for the year ended March 31, 2023. It references the earnings call and provides a link to the audio recording on the company's website. The document is short (1242 characters) and serves as an announcement rather than containing the actual earnings results or transcript. Therefore, it is not the earnings release itself nor a call transcript but an announcement related to the earnings call audio recording. Given the options, the closest classification is Earnings Release (ER) since it relates to earnings results, but since it only announces the audio recording availability and does not contain financial highlights, the best fit is Regulatory Filings (RNS) as a general announcement. However, since the document specifically mentions 'Results Earnings Call Audio Recording' and is an announcement of the earnings call audio, the most appropriate classification is Call Transcript (CT) category, which includes full text transcripts of earnings calls. But this document is not a transcript, only an announcement of the audio recording. Hence, by the MENU VS MEAL rule, this is an announcement, not the transcript itself. Therefore, the correct classification is Regulatory Filings (RNS).
2023-05-02 English
Investor Presentation
Regulatory Filings
2023-05-02 English
Copy of Newspaper Publication
Regulatory Filings
2023-04-29 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance with Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions the disclosure of Related Party Transactions for the half year ended March 31, 2023. The document is short (1247 characters) and appears to be a regulatory compliance announcement rather than the actual financial report or detailed related party transaction report. It does not contain substantive financial data or detailed analysis but is a notification to take the disclosure on record. Therefore, it fits best under Regulatory Filings (RNS) as a compliance disclosure announcement.
2023-04-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.